News Major shareholder announcement – BlackRock, Inc. Staff September 11, 2023 Post Views: 39 Related Continue Reading Previous Invivyd Announces Dosing of First Participant in CANOPY Phase 3 Pivotal Clinical Trial Investigating VYD222 for the Prevention of Symptomatic COVID-19 Next Scinai Immunotherapeutics Ltd. to participate this week in H.C. Wainwright 25th Annual Global Investment Conference in New York and LSX USA Congress 2023 in Boston More Stories Healthcare News NuGen Medical Completes Delivery and First Sale of 500 InsuJet(TM) Devices and Consumables in Romania Staff September 20, 2023 News Izotropic Closes Non-Brokered Private Placement Staff September 20, 2023 News Yada Yoga Extends Wellness Support to Protestors in the Entertainment Industry on the Picket Lines Staff September 20, 2023
